Managing Knee Pain in Hemodialysis Patients

Initial Assessment

The American Journal of Kidney Diseases recommends investigating for peripheral vascular disease (PVD) as dialysis patients have high rates of vascular complications that may manifest as knee or limb pain, with careful assessment of arterial pulses and skin integrity, particularly in diabetic dialysis patients 3, 1
Approximately 58% of hemodialysis patients experience pain, with many rating it moderate to severe, and pain in this population is strongly associated with lower quality of life, psychosocial distress, insomnia, and depression 1, 2

The American College of Cardiology recommends exercise therapy as primary treatment, targeting moderate-intensity physical activity for at least 150 minutes per week, and local heat application provides significant relief without affecting renal function 1, 2, 4
Music therapy during dialysis sessions can reduce pain perception and improve overall symptom burden, and consider cognitive behavioral therapy, mindfulness, and meditation as these lack adverse effects and medication interactions 5, 6

Acetaminophen is the safest first-line medication for mild to moderate pain, with a maximum daily dose of 3000 mg/day, and prescribe on a regular schedule rather than "as required" for chronic pain 4, 1, 2

Topical analgesics such as lidocaine 5% patch and diclofenac gel can be used for localized knee pain without significant systemic absorption, and gabapentin or pregabalin for neuropathic pain components, but require significant dose adjustment in hemodialysis patients 4, 1, 2

Fentanyl and buprenorphine are the safest opioid options for hemodialysis patients due to favorable pharmacokinetic profiles, and implement opioid risk mitigation strategies and obtain informed consent after discussing goals, expectations, risks, and alternatives 4, 1, 2

NSAIDs (including COX-2 inhibitors) should generally be avoided in hemodialysis patients due to nephrotoxic effects, though may be used for short durations with careful monitoring, and SSRIs have not shown consistent benefit over placebo in hemodialysis patients and have documented increased adverse effects 2, 5
Avoid ankle-brachial index (ABI) for PVD screening as it may be falsely elevated due to vascular calcification; toe-brachial index (TBI) is not affected by calcification, and do not automatically proceed to amputation if PVD is diagnosed—revascularization (surgical or angioplasty with stent) is appropriate for carefully selected ambulatory patients who use the limb for weight-bearing 3, 1

Consider referral to physical therapy for structured exercise programs, and consider referral to pain management specialists when pain is refractory to initial interventions, and if PVD with claudication or critical limb ischemia is suspected, evaluate for revascularization in selected patients rather than defaulting to primary amputation 1, 2, 3

Aerobic exercise has been shown to decrease depressive symptom burden in hemodialysis patients, supporting its use according to patient ability, and there are no long-term studies on analgesic use in hemodialysis patients, requiring careful attention to efficacy and safety with ongoing monitoring 5, 4, 2